Wellesley Pharmaceuticals Developer of Paxerol

100 million people in the US suffer from a problem for which we have a strong solution and six patents issued.


Wellesley Pharmaceuticals currently in clinical trials for an innovative, patented drug for the treatment of Nocturia.  Our proprietary drug, Paxerol™ addresses a substantial unmet clinical need.


Paxerol offers significant advancement in terms of mechanism of action relative to existing indirect treatments of nocturia and should allow us to provide relief to hundreds of millions of people.

© 2016 Wellesley Pharmaceuticals,   All Rights Reserved